384 results on '"GÜRTLER, LUTZ"'
Search Results
2. HIV transmission by human bite: a case report and review of the literature—implications for post-exposure prophylaxis
3. Cytokines and chemokines involved in the defense reaction against HIV-1 and hepatitis B virus: isn’t it time to use a standardized nomenclature of the involved mediators?
4. COVID-19: A case for plasma derived natural anticoagulants?
5. “Thromboinflammation in COVID-19: can α2-macroglobulin help to control the fire?”: Comment from Seitz et al.
6. Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?
7. Aspects on the history of transmission and favor of distribution of viruses by iatrogenic action: perhaps an example of a paradigm of the worldwide spread of HIV
8. HIV-2EU–Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update
9. HIV in Africa
10. Biology of Sexually Transmitted Herpes Viruses
11. Clinical Aspects of HCMV Infections in Immunocompromised Patients
12. HIV-2EU: Supporting Standardized HIV-2 Drug Resistance Interpretation in Europe
13. Die Evolution der Histokompatibilitätsantigene
14. Transfusion-Related Acute Lung Injury
15. Sexuell übertragene Infektionen (STI)
16. Prevalence- and Gender-Specific Immune Response to Opportunistic Infections in HIV-Infected Patients in Lesotho
17. Humane Pocken (Affen-, Kuh- und Yatapocken)
18. Sequence Analysis of Neuroinvasive and Blood-Derived HIV-1 nef Genes
19. Von Strafe und Segen.
20. Tollwut (Rabies, Lyssa)
21. Influenza
22. Neue Influenza A (H1N1) 2009
23. Reducing Blood Transfusion
24. Prima Klima?
25. Fluch und Segen
26. Virulenz und Aminosäure-Mutationen des SARS-CoV-2: Wie entwickelt sich SARS-CoV-2 weiter?
27. Virulenz und Aminosäure-Mutationen des Influenzavirus A: Harmloser Schnupfen oder tödliche Pneumonie.
28. SARS-CoV-2-Impfstoffe und Reaktion des Immunsystems. Kann die epidemische Ausbreitung des Virus durch Impfung verhindert werden?
29. Die Evolution von HIV, dem humanen Immunschwächevirus
30. Regional spread of HIV-1 M subtype B in middle-aged patients by random env-C2V4 region sequencing
31. Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus
32. Gastrozeit.
33. Rückkehr der Virusinfektionen.
34. COVID-19 Convalescent Plasma: No Definite Answer Yet
35. Zur Bedeutung des Blutspenderscreenings
36. COVID‐19‐associated coagulopathy ‐ Hypothesis: Are Children protected due to enhanced thrombin inhibition by higher α2‐Macroglobulin (α2‐M)?
37. A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region
38. Überlegungen zur Schutzdauer
39. Was wir bisher wissen
40. Thromboinflammation in COVID‐19: Can α2‐macroglobulin help to control the fire?
41. Comparison of the efficacy of virus inactivation methods in allogeneic avital bone tissue transplants
42. Seropositivity for anti-Borrelia IgG antibody is independently associated with carotid atherosclerosis
43. Inhibition of adenovirus DNA polymerase by modified nucleoside triphosphate analogs correlate with their antiviral effects on cellular level
44. Convalescent plasma for administration of passive antibodies against viral agents
45. Die Rolle des angeborenen Immunsystems bei COVID-19: ein zweischneidiges Schwert
46. COVID‐19‐associated coagulopathy—Hypothesis: Are children protected due to enhanced thrombin inhibition by higher α2‐Macroglobulin macroglobulin (α2‐M)?
47. Vorteile für Individuum und Population.
48. First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany
49. Von Menschen und Schweinen.
50. Inhibition of Tryptase TL2 from Human T4+ Lymphocytes and Inhibition of HIV-1 Replication in H9 Cells by Recombinant Aprotinin and Bikunin Homologues
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.